Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky

Masters of Scale

With the help of co-founder Mark Cuban, Cost Plus Drugs CEO Alex Oshmyansky is radically re-engineering the pharma marketplace and dramatically cutting the price for many prescription drugs. Oshmyansky joins Rapid Response host Bob Safian to share his amazing journey — from struggling as an immigrant in primary school to starting college at age 13, how medical practice led to entrepreneurship, plus reimagining his original plan on advice from the legendary incubator Y Combinator. Oshmyansky explains how Cost Plus Drugs stumbled into success, turning adversaries into allies and harnessing patience as a superpower.

For more info, visit: www.rapidresponseshow.com

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More description

With the help of co-founder Mark Cuban, Cost Plus Drugs CEO Alex Oshmyansky is radically re-engineering the pharma marketplace and dramatically cutting the price for many prescription drugs. Oshmyansky joins Rapid Response host Bob Safian to share his amazing journey — from struggling as an immigrant in primary school to starting college at age 13, how medical practice led to entrepreneurship, plus reimagining his original plan on advice from the legendary incubator Y Combinator. Oshmyansky explains how Cost Plus Drugs stumbled into success, turning adversaries into allies and harnessing patience as a superpower.

For more info, visit: www.rapidresponseshow.com

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

2024-12-03 28 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.